Systematic transrectal prostate biopsy serves as a standard method for the collection of tissue samples to confirm the diagnosis in patients with clinical suspicion of PCa based on elevated levels of PSA and/or abnormal findings on digital rectal examination (DRE) [13,14]. The gene discussed is KLK3; the disease is posterior cortical atrophy.